| Income Statement |
| Total Revenue | 22.50M |
|
| Revenues (USD) | 22.50M |
| Cost of Revenue | 5.99M |
| Gross Profit | 16.51M |
| Operating Expenses | 14.50M |
| Research and Development Expense | 7.57M |
| Selling, General and Administrative Expense | 6.93M |
| Operating Income | 2.01M |
| Income Tax Expense | 371.00K |
| Net Income | 2.42M |
| Net Income Common Stock | 2.42M |
| Net Income Common Stock (USD) | 2.42M |
| Consolidated Income | 2.42M |
| Earnings per Basic Share | 0.09 |
| Earnings per Basic Share (USD) | 0.09 |
| Earnings per Diluted Share | 0.09 |
| Earning Before Interest & Taxes (EBIT) | 2.79M |
| Earning Before Interest & Taxes (USD) | 2.79M |
| Weighted Average Shares | 27.42M |
| Weighted Average Shares Diluted | 28.14M |
| Balance Sheet |
| Cash and Equivalents | 80.47M |
| Cash and Equivalents (USD) | 80.47M |
| Trade and Non-Trade Receivables | 8.72M |
| Current Assets | 93.15M |
| Property, Plant & Equipment Net | 3.74M |
| Total Assets | 139.69M |
| Debt Current | 1.51M |
| Total Debt | 3.14M |
| Current Liabilities | 43.33M |
| Debt Non-Current | 1.63M |
| Total Liabilities | 48.13M |
| Accumulated Retained Earnings (Deficit) | -283.83M |
| Accumulated Other Comprehensive Income | -1.66M |
| Shareholders Equity | 91.56M |
| Shareholders Equity (USD) | 91.56M |
| Assets Non-Current | 46.54M |
| Total Debt (USD) | 3.14M |
| Deferred Revenue | 34.05M |
| Goodwill and Intangible Assets | 15.34M |
| Liabilities Non-Current | 4.80M |
| Trade and Non-Trade Payables | 1.52M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 407.00K |
| Net Cash Flow from Financing | 223.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.60M |
| Capital Expenditure | -64.00K |
| Issuance (Purchase) of Equity Shares | 223.00K |
| Net Cash Flow from Investing | -64.00K |
| Net Cash Flow from Operations | -1.81M |
| Effect of Exchange Rate Changes on Cash | -947.00K |
| Share Based Compensation | 789.00K |